Posts

Showing posts with the label research

New research reveals the most common crypto scams in 2023

Blackmail and ransomware are the most common crypto scams, a new research shows. Explore how to protect your funds. Cryptocurrencies have promised innovation but have also seen their fair share of wrongdoing, especially in the form of scams that have left investors counting their losses. According to Chainanalysis, while the first half of 2023 saw a reduction in crypto scam revenue by nearly $3.3 billion compared to 2022, totaling just over $1.0 billion, ransomware remained a persistent issue. Ransomware attackers managed to extort approximately $175.8 million more during this period than in the previous year. Meanwhile, in the third quarter of 2023 alone, the number of crypto hacks and scams skyrocketed by nearly 60% compared to the same period in 2022, with nearly $686 million lost to fraudulent activities. A notable incident within this period was the Mixin hack on Sep. 25, where attackers made away with roughly $200 million. Let’s delve deeper and explore various types of scam...

Neuralink gets FDA approval for ‘in-human’ trials of its brain-computer interface

Image
The Neuralink device is designed to be surgically implanted and, according to CEO Elon Musk, will eventually be marketed to the general public. Elon Musk’s brain -computer interface (BCI) startup, Neuralink, reportedly received approval from the United States Food and Drug Administration (FDA) to conduct some form of “in- human ” trials for its surgically implanted brain device.  Congratulations Neuralink team! https://t.co/AWZGf33UDr — Elon Musk (@elonmusk) May 26, 2023 It’s unclear at this time what kind of trials the Neuralink tweet is referring to — the only other information mentioned was that the company isn’t accepting applicants yet. Neuralink was denied the FDA’s approval for human trials in early 2022 over several concerns related to safety, which, at the time, the company was reportedly working to resolve. The FDA’s apparent U-turn would indicate that such concerns have been worked out, and the company should then be free to conduct limited testing of its sur...